Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D93UYR
|
|||
Drug Name |
LIB003
|
|||
Drug Type |
Fusion protein
|
|||
Indication | Hypercholesterolaemia [ICD-11: 5C80.0; ICD-9: 272] | Phase 3 | [1] | |
Company |
LIB Therapeutics Cincinnati, OH
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Proprotein convertase subtilisin/kexin type 9 (PCSK9) | Target Info | Inhibitor | [1] |
WikiPathways | PCSK9-mediated LDLR degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT05234775) Cross-Over Study to Compare the Pharmacokinetics and Pharmacodynamics of LIB003 Process 1 and Process 2 Drug Product in Subjects With or Without Statin Therapy. U.S.National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.